Providence Capital Advisors LLC Makes New Investment in Stryker Co. (NYSE:SYK)

Providence Capital Advisors LLC acquired a new stake in shares of Stryker Co. (NYSE:SYK - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm acquired 13,615 shares of the medical technology company's stock, valued at approximately $4,902,000.

A number of other large investors also recently modified their holdings of the company. Kohmann Bosshard Financial Services LLC purchased a new position in shares of Stryker in the fourth quarter worth $25,000. Dunhill Financial LLC increased its holdings in Stryker by 94.9% in the 3rd quarter. Dunhill Financial LLC now owns 76 shares of the medical technology company's stock valued at $27,000 after acquiring an additional 37 shares during the last quarter. Rakuten Securities Inc. lifted its stake in Stryker by 618.2% in the 4th quarter. Rakuten Securities Inc. now owns 79 shares of the medical technology company's stock worth $28,000 after purchasing an additional 68 shares in the last quarter. Centricity Wealth Management LLC bought a new position in shares of Stryker during the 4th quarter valued at about $30,000. Finally, BankPlus Trust Department purchased a new position in shares of Stryker during the fourth quarter valued at about $33,000. Hedge funds and other institutional investors own 77.09% of the company's stock.

Wall Street Analyst Weigh In

A number of research firms recently commented on SYK. Wells Fargo & Company boosted their target price on Stryker from $427.00 to $435.00 and gave the stock an "overweight" rating in a research report on Wednesday, January 29th. Needham & Company LLC reaffirmed a "buy" rating and set a $442.00 price objective on shares of Stryker in a report on Friday, March 21st. Canaccord Genuity Group raised their target price on shares of Stryker from $420.00 to $435.00 and gave the company a "buy" rating in a report on Wednesday, January 29th. StockNews.com downgraded shares of Stryker from a "buy" rating to a "hold" rating in a research note on Thursday, March 6th. Finally, The Goldman Sachs Group set a $422.00 price objective on shares of Stryker in a research report on Tuesday, March 4th. Five equities research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $421.90.

Remove Ads

Insider Activity

In other news, Director Ronda E. Stryker sold 201,392 shares of the company's stock in a transaction dated Friday, January 31st. The shares were sold at an average price of $392.24, for a total transaction of $78,993,998.08. Following the transaction, the director now owns 3,642,075 shares in the company, valued at $1,428,567,498. This represents a 5.24 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Allan C. Golston sold 2,458 shares of Stryker stock in a transaction that occurred on Tuesday, February 18th. The stock was sold at an average price of $383.07, for a total transaction of $941,586.06. Following the completion of the sale, the director now owns 14,895 shares of the company's stock, valued at $5,705,827.65. This trade represents a 14.16 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 5.90% of the company's stock.

Stryker Stock Up 0.0 %

SYK stock traded up $0.09 during trading on Tuesday, reaching $372.34. 293,924 shares of the company traded hands, compared to its average volume of 1,442,678. The business has a 50 day simple moving average of $383.86 and a 200 day simple moving average of $374.41. Stryker Co. has a 12 month low of $314.93 and a 12 month high of $406.19. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.32 and a current ratio of 1.95. The company has a market capitalization of $142.12 billion, a price-to-earnings ratio of 47.98, a price-to-earnings-growth ratio of 2.93 and a beta of 0.95.

Stryker (NYSE:SYK - Get Free Report) last released its quarterly earnings results on Tuesday, January 28th. The medical technology company reported $4.01 earnings per share for the quarter, beating analysts' consensus estimates of $3.87 by $0.14. Stryker had a net margin of 13.25% and a return on equity of 23.58%. During the same period in the previous year, the company posted $3.46 EPS. On average, equities research analysts anticipate that Stryker Co. will post 13.47 earnings per share for the current fiscal year.

Stryker Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, April 30th. Stockholders of record on Monday, March 31st will be given a dividend of $0.84 per share. This represents a $3.36 dividend on an annualized basis and a dividend yield of 0.90%. The ex-dividend date is Monday, March 31st. Stryker's payout ratio is presently 43.30%.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.